Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model

被引:0
|
作者
Kevin A. Guttenplan
Maya K. Weigel
Drew I. Adler
Julien Couthouis
Shane A. Liddelow
Aaron D. Gitler
Ben A. Barres
机构
[1] School of Medicine,Department of Neurobiology
[2] Stanford University,Department of Genetics
[3] School of Medicine,Department of Neuroscience and Physiology
[4] Stanford University,Department of Ophthalmology
[5] Neuroscience Institute,undefined
[6] NYU School of Medicine,undefined
[7] NYU School of Medicine,undefined
[8] NYU School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Reactive astrocytes have been implicated in the pathogenesis of neurodegenerative diseases, including a non-cell autonomous effect on motor neuron survival in ALS. We previously defined a mechanism by which microglia release three factors, IL-1α, TNFα, and C1q, to induce neurotoxic astrocytes. Here we report that knocking out these three factors markedly extends survival in the SOD1G93A ALS mouse model, providing evidence for gliosis as a potential ALS therapeutic target.
引用
收藏
相关论文
共 50 条
  • [21] Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model
    Wood, Tara E.
    Barry, Joshua
    Yang, Zhenquin
    Cepeda, Carlos
    Levine, Michael S.
    Gray, Michelle
    HUMAN MOLECULAR GENETICS, 2019, 28 (03) : 487 - 500
  • [22] Silencing Neuroinflammatory Reactive Astrocyte Activating Factors Ameliorates Disease Outcomes in Perinatal White Matter Injury.
    Lutz, Amanda Brosius
    Renz, Patricia
    Tscherrig, Vera
    Steinfort, Marel
    Haesler, Valerie
    Huang, Eric
    Chevali, Manideep
    Rowitch, David
    Liddelow, Shane
    Schoeberlein, Andreina
    Surbek, Daniel
    REPRODUCTIVE SCIENCES, 2024, 31 : 90A - 90A
  • [23] Survival motor neuron protein upregulation slows disease progression in a mouse model of amyotrophic lateral sclerosis
    Perera, N.
    Sheean, R.
    Crouch, P.
    White, A.
    Horne, M.
    Turner, B.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 204 - 204
  • [24] The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model
    Inoue, H
    Tsukita, K
    Iwasato, T
    Suzuki, Y
    Tomioka, M
    Tateno, M
    Nagao, M
    Kawata, A
    Saido, TC
    Miura, M
    Misawa, H
    Itohara, S
    Takahashi, R
    EMBO JOURNAL, 2003, 22 (24): : 6665 - 6674
  • [25] A method comparison in monitoring disease progression of G93A mouse model of ALS
    Zhou, Chang
    Zhao, Cui-Ping
    Zhang, Chen
    Wu, Guo-Yong
    Xiong, Fu
    Zhang, Cheng
    AMYOTROPHIC LATERAL SCLEROSIS, 2007, 8 (06): : 366 - 372
  • [26] OPTOGENETIC RESCUE OF SLEEP SLOWS ALZHEIMER'S PROGRESSION IN A MOUSE MODEL
    Kastanenka, Ksenia
    SLEEP, 2024, 47
  • [27] Expansion of suppressor tregs by IL-2/IL-2 MAB complexes slows disease progression in the mutant SOD1 mouse model of ALS
    Sheean, R.
    McKay, F.
    Cretney, E.
    Scheller, K.
    Perera, N.
    Yerbury, J.
    Vucic, S.
    Turner, B.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 206 - 207
  • [28] Humoral factors in ALS patients during disease progression
    Jared Ehrhart
    Adam J. Smith
    Nicole Kuzmin-Nichols
    Theresa A. Zesiewicz
    Israt Jahan
    R. Douglas Shytle
    Seol-Hee Kim
    Cyndy D. Sanberg
    Tuan H. Vu
    Clifton L. Gooch
    Paul R. Sanberg
    Svitlana Garbuzova-Davis
    Journal of Neuroinflammation, 12
  • [29] Humoral factors in ALS patients during disease progression
    Ehrhart, Jared
    Smith, Adam J.
    Kuzmin-Nichols, Nicole
    Zesiewicz, Theresa A.
    Jahan, Israt
    Shytle, R. Douglas
    Kim, Seol-Hee
    Sanberg, Cyndy D.
    Vu, Tuan H.
    Gooch, Clifton L.
    Sanberg, Paul R.
    Garbuzova-Davis, Svitlana
    JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [30] Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease
    Ishiyama, T
    Okada, R
    Nishibe, H
    Mitsumoto, H
    Nakayama, C
    BRAIN RESEARCH, 2004, 1019 (1-2) : 226 - 236